Unjoni Ewropea - Ingliż - EMA (European Medicines Agency)

roche registration gmbh - epoetin beta - kidney failure, chronic; anemia; cancer; blood transfusion, autologous - antianemic preparations - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients;treatment of symptomatic anaemia in adult patients with non-myeloid malignancies receiving chemotherapy;increasing the yield of autologous blood from patients in a pre-donation programme. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anaemia (hb 10 - 13 g/dl [6.21 - 8.07 mmol/l], no iron deficiency) if blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males).

Singapor - Ingliż - HSA (Health Sciences Authority)

novem healthcare pte ltd - general & plastic surgery - take the fat off the canister to syringes for autologous fat reinjection

Singapor - Ingliż - HSA (Health Sciences Authority)

medtronic international, ltd. - general hospital - the autolog iq autotransfusion system and medtronic wash kit are intended for use in the collection, concentration, washing, and reinfusion of autologous blood. areas of application may include, but are not limited to, the following: • surgeries including general, cardiovascular, orthopedic, vascular, plastic/reconstructive, obstetric/gynecologic, and neurological • postoperative treatment areas

Singapor - Ingliż - HSA (Health Sciences Authority)

medtronic international, ltd. - cardiovascular - intended for use in the in the collection, concentration, washing and reinfusion of autologous blood.

Unjoni Ewropea - Ingliż - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymphoma, mantle-cell - antineoplastic agents - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor.acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

australian orthopaedic fixations pty ltd - 64707 - wound therapy autologous blood clot preparation kit - a sterile, single use kit comprising a beaker and stirring rod, used to create an autologous whole blood clot tissue mass from blood already drawn from a patient undergoing surgery.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

euro implants pty ltd -

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

swedish orphan biovitrum ltd - autologous human cartilage cells - implantation suspension - 10000cell/1microlitre

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

co.don ag - autologous chondrocyte spheroids - implantation suspension

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

co.don ag - autologous chondrocyte spheroids - implantation suspension